SUBJECTS : Multiple Sclerosi
Multiple Sclerosis International: 2018, vol: 2018, issue:
- 1)- Rafiyah Khan, Alan Uren, Luke Canham, David Cottrell, Marcus J Drake, Nikki Cotterill. What Are the Participants' Perspectives of Taking Melatonin for the Treatment of Nocturia in Multiple Sclerosis? A Qualitative Study Embedded within a Double-Blind RCT. Multiple sclerosis international. 2018, 2018: 4721505
Cited : 4Read More - 2)- S M K Gamage, I Wijeweera, S B Adikari, Katharina Fink, Jan Hillert, Anna Fogdell-Hahn, H M A Sominanda. Multiple Sclerosis Patients with Markedly Low Intrathecal Antibody Response in Sri Lanka. Multiple sclerosis international. 2018, 2018: 5342936Cited : 2Read More
- 3)- Eleni Konstantinopoulou, Panagiotis Ioannidis, Christos Bakirtzis, Virginia Giantzi, Theodora Afrantou, Dimitrios Parissis, Lambros Messinis, Grigorios Nasios, Nikolaos Grigoriadis. Estimating Everyday Neuropsychological Functioning in Multiple Sclerosis: Reliability and Validity of the Greek Multiple Sclerosis Neuropsychological Questionnaire. Multiple sclerosis international. 2018, 2018: 6301535Cited : 1Read More
- 4)- Maddalena Sparaco, Luigi Lavorgna, Renata Conforti, Gioacchino Tedeschi, Simona Bonavita. The Role of Wearable Devices in Multiple Sclerosis. Multiple sclerosis international. 2018, 2018: 7627643Cited : 24Read More
- 5)- Mireille Neuhaus, Pasquale Calabrese, Jean-Marie Annoni. Decision-Making in Multiple Sclerosis Patients: A Systematic Review. Multiple sclerosis international. 2018, 2018: 7835952Cited : 7Read More
- 6)- Maria P Gontika, Maria C Anagnostouli. Anti-Myelin Oligodendrocyte Glycoprotein and Human Leukocyte Antigens as Markers in Pediatric and Adolescent Multiple Sclerosis: on Diagnosis, Clinical Phenotypes, and Therapeutic Responses. Multiple sclerosis international. 2018, 2018: 8487471Cited : 4Read More
